The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of phase Ib of anticancer stem cell antibody tarextumab (OMP-59R5, TRXT, anti-Notch 2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC).
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Aduro Biotech; Astellas Pharma (I); Celgene; Celsion (I); Cipla; Exelixis (I); Hexal (I); IntegraGen (I); Jennerex (I); Lilly (I); MedImmune; Novartis (I); Pharmacyclics; Sanofi; Silenseed; Vicus Therapeutics (I)
Research Funding - Clovis Oncology (Inst); Immunomedics (Inst); Incyte (Inst); Momenta Pharmaceuticals (Inst); Myriad Genetics (Inst); OncoMed (Inst)
 
Lon S. Smith
Research Funding - OncoMed (Inst)
 
Johanna C. Bendell
Research Funding - OncoMed (Inst)
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer/Onyx; Marval Biosciences
Research Funding - Abbvie (Inst); ArQule (Inst); Bayer (Inst); Eisai (Inst); Exelixis (Inst); Gilead Sciences (Inst); Lilly (Inst); MethylGene (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Mark Zalupski
Research Funding - OncoMed (Inst)
 
William Gluck
Research Funding - OncoMed (Inst)
 
Ann Kapoun
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Wan-Ching Yen
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Lu Xu
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Dawn Hill
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Lei Zhou
Consulting or Advisory Role - OncoMed
 
Jakob Dupont
Employment - OncoMed
Stock and Other Ownership Interests - OncoMed
 
Allen Lee Cohn
Honoraria - Celgene; onyx; Sanofi
Speakers' Bureau - Celgene; Lilly; Sanofi